22nd Century Group Signs Three-Year Exclusive Agreement with Cookies

Apr.06.2023

22nd Century Group partners with Cookies for exclusive three year distribution and license agreement for cannabis-based products.

On April 5th, the 22nd Century Group (XXII) signed a three-year exclusive licensing and distribution agreement with global cannabis company Cookies. The agreement covers all non-Delta-9 THC cannabis-derived consumer products of the Cookies brand, including the procurement of all raw materials and APIs, as well as the production and retail distribution of e-cigarettes and other CBD products. In the past three years, the 22nd Century Group's GVB Biopharma has already produced various Cookies products. With this new agreement, they will continue to produce Cookies' leading products and are expected to account for more than half of Cookies' non-Delta-9 THC sales.

The agreement also involves the integration of market sales and distribution, utilizing 22nd Century's senior consumer packaged goods sales team, who plan to distribute Cookies products in up to 18 markets to launch the company's innovative VLN product in 2023. The consumer goods sales team will target around 60,000 retail stores, including independent retailers, discount tobacco outlets, and e-cigarette shops in non-entertainment states, serviced by their top regional distributors and chain discount tobacco store networks. The product will also be available for sale on Cookies' e-commerce website.

22nd Century Group, Inc. is a biotech company focused on altering the nicotine content in tobacco plants and the cannabinoid content in cannabis plants through genetic engineering, gene editing, and modern plant breeding. Its primary goal in the tobacco industry is to introduce cigarettes with 95% less nicotine than traditional cigarettes in the US and international markets.

References:

22nd Century has agreed to a partnership with Cookies.

#Asia #Market #China #Disposable e-cigarettes

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

South Korea Implements Public Tobacco Harmfulness Management Program, Including 22 Harmful Components in E-Cigarettes

South Korea’s Ministry of Health and Welfare and the Ministry of Food and Drug Safety convened the first 2025 Tobacco Harmfulness Management Policy Committee, finalizing new lists of harmful substances for cigarettes, heated tobacco products, and liquid e-cigarettes to be publicly disclosed from next year.

Nov.14 by 2FIRSTS.ai

FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection

In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.

Oct.10

PMI Compares Smoke-Free Policies in Three Countries: Japan and New Zealand Lead Tobacco Control, While Thailand’s Ban Stalls Harm Reduction

PMI Malaysia says Japan and New Zealand’s regulated smoke-free alternatives have hastened smoking declines, whereas Thailand’s post-2014 ban drives smokers to cigarettes or the black market—evidence, PMI argues, that pairing regulated alternatives with traditional controls could improve public health faster.

Oct.15 by 2FIRSTS.ai

UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative

Lord Strathcarron, a member of the UK House of Lords, has admitted to discussing the government’s Tobacco and Vapes Bill with a relative who holds a senior role at British American Tobacco (BAT). He is advocating amendments to scrap the bill’s core “generational smoking ban” provision, raising questions of potential conflict of interest.

Oct.27